Abstract:Quality marker (Q-marker) serves as an important driver for the standardization of quality control in traditional Chinese medicine (TCM) formulas. However, it is still challenging to discover comprehensive and representative Q-markers. This study aimed to identify Q-markers of Hugan tablet (HGT), a famous TCM formula with ideal clinical effects in liver diseases. Here, we proposed a funnel-type stepwise filtering strategy that integrated secondary metabolites characterization, characteristic chromatogram, quantitative analysis, literature mining, biotransformation rules and network analysis. Firstly, the strategy of "secondary metabolites-botanical drugs-TCM formula" was applied to comprehensively identify the secondary metabolites of HGT. Then, the secondary metabolites with specificity and measurability in each botanical drug were identified by HPLC characteristic chromatogram, biosynthesis pathway and quantitative analysis. Based on literature mining, the effectiveness of botanical metabolites that met the above conditions was evaluated. Furthermore, the metabolism of the above metabolites in vivo was studied to reveal their biotransformation forms, which were used for network analysis. At last, according to biotransformation rules of the prototype drugs in vivo , the secondary metabolites were traced and preliminarily chosen as Q-markers. As a result, 128 plant secondary metabolites were identified in HGT, and 11 specific plant secondary metabolites were screened out. Then, the content of specific plant secondary metabolites in 15 batches of HGT was determined, which confirmed their measurability. And the results of literature mining showed that eight secondary metabolites had therapeutic effects in treating liver disease at the in vivo level, and three secondary metabolites inhibited liver disease-related indicators at the in vitro level. After that, 26 compounds absorbed into the blood (11 specific plant metabolites and their 15 metabolites in vivo ) were detected in rats. Moreover, 14 compounds, including prototype components and their metabolites, were selected as Q-marker candidates by the "TCM formula-botanical drugs-compounds-targets-pathways" network. Finally, 9 plant secondary metabolites were defined as comprehensive and representative Q-markers. Our study not only provides a scientific basis for the improvement and secondary development of the quality standard of HGT, but also proposes a reference method for discovering and identifying Q-markers of TCM preparations.

Compound to Extract to Formulation: A Knowledge-Transmitting Approach for Metabolites Identification of Gegen-Qinlian Decoction, A Traditional Chinese Medicine Formula

Characterization of the Chemical Constituents in Da-Huang-Gan-Cao-Tang by Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Tandem Mass Spectrometry and Liquid Chromatography Coupled with Ion Trap Mass Spectrometry

Simultaneous Quantification of 50 Bioactive Compounds of the Traditional Chinese Medicine Formula Gegen-Qinlian Decoction Using Ultra-High Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry

Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis.

A strategy for intelligent chemical profiling-guided precise quantitation of multi-components in traditional Chinese medicine formulae-QiangHuoShengShi decoction

Metabolites Identification and Pharmacokinetic Studies of Chinese Herbal Medicines

A Comprehensive Strategy Based on UPLC-Q/TOF-MS for the Identification of Compounds in a Chinese Patent Medicine, Xiao'er Chiqiao Qingre Granules

An In-House Database-Driven Untargeted Identification Strategy for Deep Profiling of Chemicalome in Chinese Medicinal Formula.

Simultaneous Determination in Rat Plasma of Eleven Bioactive Components of Gengen Qinlian Decoction by LC-Tandem Mass Spectrometry and Application in Pharmacokinetic Studies

Rapid Characterization of Chemical Constituents and Rats Metabolites of the Traditional Chinese Patent Medicine Gegen-Qinlian-Wan by UHPLC/DAD/qTOF-MS

A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Qingkailing Injection in Rat Urine by High‐performance Liquid Chromatography with Tandem Mass Spectrometry

A Combination of Representative Compounds, Metabolism Platform and Diagnostic Extraction Strategy for Characterization of Metabolites of Shuang-Huang-Lian Oral Liquid in Vivo by Ultra-Performance Liquid Chromatography Coupled with Time-of-flight Mass Spectrometry.

A systematic strategy integrating solid-phase extraction, full scan range splitting, mass defect filter and precursor ion list for comprehensive metabolite profiling of Danqi Tongmai tablet in rats

Identification Of Metabolites Of Complicated Qingkailing In Rat

Characterization of Global Metabolic Profile of Zhi-Zi-Hou-Po Decoction in Rat Bile, Urine and Feces after Oral Administration Based on a Strategy Combining LC–MS and Chemometrics

An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case

Identification and characterization of chemical constituents in Mahuang Guizhi Decoction and their metabolites in rat plasma and brain by UPLC-Q-TOF/MS

Identification of prototype compounds and their metabolites in rats' serum from Xuefu Zhuyu Decoction by UPLC-Q-TOF/MS

Metabolic Profiling Of Guanxin Ii Prescription Based On Metabolic Fingerprinting And Chemical Analysis

A multidimensional strategy to rapidly identify the chemical constituents in Shengxian Decoction by using ultra‐performance liquid chromatography coupled with ion mobility spectrometry quadrupole time‐of‐flight mass spectrometry

A funnel-type stepwise filtering strategy for identification of potential Q-markers of traditional Chinese medicine formulas